Businessd R&D and Innovation Survey

Business R&D and Innovation Survey

Attachment C-QbyQBRDI-1 (long form)

Businessd R&D and Innovation Survey

OMB: 0607-0912

⚠️ Notice: This form may be outdated. More recent filings and information on OMB 0607-0912 can be found here:

Document [docx]

Download: docx | pdf

2014 BRDIS - Guidelines

General guidelines for reporting inter-company transactions in this survey:

Reporting for “worldwide activities”- The reporting unit is your company, including all domestic and foreign subsidiaries that are more than 50% owned by your company for financial reporting purposes. All transactions between subdivisions within this reporting unit should be eliminated as inter-company transactions. For reporting purposes, your foreign parent (if you are foreign owned) and any foreign affiliates your company does not own by more than 50% should not be treated as part of ‘your company’ in your report. Transactions with these units should be treated the same as with any unrelated third parties such as business partners, customers, or suppliers you do not own.

Reporting for “domestic operations”- In this survey “domestic operations” refers to your company’s operations located in the 50 United States and D.C. When reporting for your domestic operations, include transactions with foreign subsidiaries. For example, Question 1-9 asks how much of your company’s total sales and revenues were from your company’s domestic operations. All revenue from the domestic operations, including sales to subsidiaries or affiliated companies overseas, should be reported in this question.

Section 1: Company Information

1-1 Was your company a majority-owned subsidiary of a foreign company in 2014?

Question 1-1 asks about the ownership of the company receiving the survey. Special reporting instructions apply to companies that were majority-owned by a foreign company. If your answer is “No” skip to question 1-3. If your answer is “Yes”, enter the name of the parent company andcontinue to question 1-2.

REPORTING INSRUCTIONS FOR FOREIGN-OWNED COMPANIES:

If you are owned by a foreign parent, the reporting unit for the survey is your U.S.-located company, including all your majority-owned subsidiaries and divisions regardless of location. For reporting purposes, your foreign parent and any foreign affiliates your company does not own should be treated the same as any business partner, customer, or supplier you do not own.

If you pay your foreign parent for R&D services, those costs should be included in your responses in Section 2 as “costs for purchased R&D services.”

If your foreign parent pays or reimburses your company for R&D services, the costs for this R&D should be included in your responses in Section 3 as “costs funded, paid for, or reimbursed by others.”

Report your survey data using U.S. generally accepted accounting principles (U.S. GAAP) as recognized by the Financial Accounting Standard Board (FASB). If your company follows International Financial Reporting Standards (IFRS), we request that you estimate any adjustments that would be required to conform to U.S. GAAP.

1-2 Did another U.S. company other than a holding company own more than 50 percent of the voting interest in your copany during 2014?

If your company is owned by a foreign parent, the reporting unit for the survey is your U.S.- located company, including all your majority-owned subsidiaries and divisions regardless of location. For reporting purposes, your foreign owner and any foreign affiliates your company does not own should be treated the same as any business partner, customer, or supplier you do not own.

If you pay your foreign parent for R&D services, those costs should be included in your responses in Section 2 as “costs for purchased R&D services.”

Question 1-2 asks about the majority of the ownership of the voting interest of the company receiving the survey. Special reporting instructions apply to companies that have been acquired by another company. If your answer is “No”, skip to question 1-3. If your answer is “Yes”, enter the name of the parent company, the EIN of the owner, and the date that your company ceased operations.

REPORTING INSTRUCTIONS FOR U.S.-OWNED COMPANIES:

If your company was purchased between April 1, 2014 and December 31, 2014, report only for the period January 1, 2013 to the date of purchase. If your company was purchased before April 1, 2014, complete Question 1-6 and return this form to the Census Bureau – you are not required to complete the rest of this survey unless your owner instructs you to complete this survey.

Example 1: Company A was acquired by Company P (a US company) on Feb. 1, 2014.

Because Company A was acquired by a US company prior to April 1, 2014, Company A is not required to complete this survey. Company A will answer question 1-6 and return the form to the Census Bureau.

Example 2: Company B is acquired by Company P (a US company) on July 1, 2014. Because Company B was acquired by a US company on or after April 1, 2014, Company B is instructed to complete the survey, reporting data for the period January 1, 2013 through July 1, 2013.

Why April 1?

The Census Bureau has determined that for this survey the benefit of collecting data from a company for a period less than one quarter of a year does not outweigh the burden placed on the company to report the data.

Why is this important?

Companies are asked this question for three reasons: to eliminate double counting in cases where both parties in a business acquisition receive the survey; to guide foreign-owned companies to special instructions; and to reduce the burden on companies who would otherwise be reporting data for a period less than one quarter of the year.

1-3 Did your company own more than 50 percent of any company operations or subsidiaries outside the 50 United States and D.C. during 2013?

Companies are instructed to include/consolidate data for their foreign subsidiaries on this survey. The reporting unit is your company, including all domestic and foreign subsidiaries in which your company owns more than 50 percent of the voting interest.

Entities in which your company does not have more than 50% ownership stake should not be included in this report as part of ‘your company’. Transactions with entities in which your company does not have more than 50% ownership stake should be reported as if they were unrelated, third parties.

If your answer is “Yes”, include data for these operations/subsidiaries in your survey responses, and skip to question 1-4. If your answer is “No”, skip to question 1-4.

Why is this important? This information is needed in order to accurately measure the impact of globalization on R&D and innovation.

1-4 Has your company ceased operations?

If your answer is “Yes”, enter the date that your company ceased operations, and skip to question 1-5. If your answer is “No”, skip to question 1-5.

REPORTING INSTRUCTIONS:

If your company ceased operations between April 1, 2013 and December 31, 2013, report only for the period January 1, 2013 to the date your company ceased operations. If your company ceased operations before April 1, 2013, complete question 1-6 and return this form to the Census Bureau – you are not required to complete the rest of this survey.

Scenario 1: Your company ceased operations before April 1, 2013. Complete questions 1-1 through 1-4 and question 1-6 on page 5 and return the survey to the Census Bureau.

Scenario 2: Your company ceased operations between April 1, 2013 and December 31, 2013. You should complete the survey as instructed and report for the period from January 1, 2013 to the date your company ceased operations.

Why April 1?

Why is this important?

Data from companies that have ceased operations during 2013 are needed in order to accurately measure the total activity of companies operating in the United States during 2013.

1-5 Did your company have discontinued operations in 2013?

Companies are instructed to include data for discontinued operations on this survey.

If your answer is “Yes”, include data for these operations in your survey responses, and skip to question 1-6. If your answer is “No”, skip to question 1-6.

Why is this important?

This information is needed in order to accurately measure the total activity of companies operating in the United States in 2013.

1-6 Who is the survey coordinator?

The survey coordinator is the person at your company responsible for gathering all requested information, ensuring instructions are followed, and submitting the completed survey. The survey coordinator may not be able to personally complete the entire survey and may need to request information from other knowledgeable resources concerning your company’s R&D, accounting, human resources, and legal matters.

Enter the following contact information for the survey coordinator: name, title, telephone number, fax number, and email address.

Why is this important?

This information gives the Census Bureau a single point of contact at each company surveyed in case questions arise about survey responses. The point of contact for this survey may differ from that for other Census Bureau surveys.

Business codes

1-7 Do the business code(s) listed below reflect all applicable codes from the list on pages

46-47 in which your company operated worldwide during 2013?

Question 1-7 asks the company receiving the survey to identify all of its worldwide businesses in 2013 (Form BRDI-1) or identify the one business that accounted for the most of its worldwide activity in 2013 (Forms BRD-1S). Most companies only have one business (such as making engine parts or providing tax preparation services) and so would only report one code for Question 1-7. Larger companies, however, sometimes operate in more than one business. These larger companies should pick the business codes from the list that best match how they define their various businesses.

If more than one of the company’s businesses falls under one of the listed business codes, the company should group those businesses together on the survey. For example, a company may have an office software business and a video game software business. For the purpose of this survey the company would group those two businesses together and report using the code for “Software publishers (except Internet)” (51120).

If more than one of the listed business codes applies to one of the company’s businesses the company should estimate what percentage of its business falls under each applicable codes. If this is not possible the company may pick the one code that is the closest match or that accounts for the largest share of its business. In either case, companies should note what action was taken in the space for "Remarks" at the end of the survey.

NOTE: These codes will be used to describe both business activities and R&D activities and may differ from industry codes used by other government surveys and reports.

If not business codes are printed below, please write in the codes from pages 46-47 that apply to your company.

If your answer is “Yes”, skip to question 1-8. If your answer is “No”, delete the code(s) that are incorrect, and, as needed, enter additional codes and descriptions from pages 46-47.

Scenario 1: The business code(s) provided are incorrect. Check the “no’ box, then find the correct code(s) on pages 46-47 and write the codes and descriptions in the boxes. Draw a line through the ones that are incorrect.

Scenario 2: No business code(s) are provided. Find the correct code(s) on pages 46-47 and write the codes and descriptions in the boxes.

For further assistance on identifying the appropriate business codes, visit the “Business Code Search Page” located on the Business Help Site at econhelp.census.gov/brdis

Why is this important?

This information is needed in order to tabulate more accurate and useful industry-level data.

1-8 What was the amount of your company’s worldwide sales and revenues during 2013?

Your company’s worldwide sales and revenue would include sales by your foreign operations and subsidiaries, as well as, revenues from domestic operations. If your company is owned by a foreign parent, report sales to your parent and those affiliates not owned by your company.

Include sales and operating revenues for discontinued operations.

Exclude non-operating income such as dividends and interest as well as excise, sales, and other revenue-based taxes. This statement is not included on the questionnaire. Is it true?

1-9 How much of the amount reported in Question 1-8 was attributable to or originated from domestic operations?

“Domestic sales” does not mean sales to customers located in the United States. If your company is owned by a foreign parent, then sales to your parent and those affiliates not owned by your company are included.

Include sales and operating revenues to foreign customers, including foreign subsidiaries.

Example: U.S. Manufacturing Corporation sells parts to customers around the world. However, because all its operations are located inside the United States, it reports 100% of its sales in this question.

1-10 How much of the 2013 sales and operating revenue amounts was for each business code listed or amended in Question 1-7:

Worldwide sales and operating revenues reported in Question 1-8
Domestic sales and operating revenues reported in Question 1-9

Transactions between one business code and another should be reported as would normally be reflected in segmental reporting. Use Line i to eliminate inter-company sales.

Product (good or service) innovation

1-11 During the three years 2012 to 2014, did your company introduce:

New or significantly improved goods (Exclude the simple resale of new goods purchased from other companies and changes of a solely aesthetic nature)?
New or significantly improved services?

For the purpose of this question, “new or significantly improved” is in reference to the company’s prior experience. For example, a computer manufacturer that introduced its first cell phone in 2012 would answer, “Yes” to line a, “New or significantly improved goods”.

A product innovation is the market introduction of a new or significantly improved good or service with respect to its capabilities, user friendliness, components, or sub-systems.

Product innovations (new or improved) must be new to your company, but they do not need to be new to your market.
Product innovations could have been originally developed by your company or by other companies.

1-12 If you answered “yes” to either 1-11, line a, or 1-11, line b, were any of your product innovations during the three years 2012 to 2014:

Question 1-12 asks whether any of the new or significantly improved product indicated in Question 1-11, lines a and b, were new or significantly improved to one of the company’s markets (i.e. first to market with a new or significantly improved product) or were only new to the company.

New to your market?

Your company introduced a new or significantly improved good or service to your market before your competitors. (it may have been available in other markets).

New only to your company?

Your company introduced a new or significantly improved good or service that was already available from your competitors in your market.

1-13 Using the definitions above, please give the percentage of your total sales in 2014 from:

Question 1-13 asks how much of the company’s total worldwide sales in 2014 are attributable to different types of product innovations. Specifically, it asks what percent of the company’s total worldwide sales in 2014 that were from:

a. New or significantly improved goods and services introduced during 2012 to 2014 that were new to your market

b. New or significantly improved goods and services introduced during 2012 to 2014 that were new only to your company

c. Goods and services that were unchanged or only marginally modified during 2012 to 2014 (include the resale of new goods or services purchased from other companies).

d. Total sales in 2014

Process innovation

1-14 During the three years 2012 to 2014, did your company introduce:

New or significantly improved methods of manufacturing or producing goods or services?
New or significantly improved logistics, delivery or distribution methods for your inputs, goods, or services?
New or significantly improved supporting activities for your processes, such as maintenance systems or operations for purchasing, accounting, or computing?

Question 1-14 asks whether the company introduced any process innovations over the past three years. For the purpose of this question, “new of significantly improved” is in reference to the company’s prior experience.

A process innovation is the implementation of a new or significantly improved production process, distribution method, or support activity for your goods or services.

Process innovations must be new to your company, but they do not need to be new to your market.
The innovation could have been originally developed by your company or by other companies.
Exclude purely organizational innovations.

Section 2: Financial Schedule A

2-1 What was the total worldwide R&D expense for your company in 2013?

Question 2-1 requests total worldwide R&D expense. The reporting unit is your company, including all domestic and foreign subsidiaries that are more 50% owned by your company for financial reporting purposes. All transactions between subdivisions within this reporting unit should be eliminated as inter-company transactions. Total worldwide R&D expense also includes payments by your company for R&D services performed by (i) unrelated third parties, (ii) affiliates for which your company has less than a 50% ownership stake and/or (iii) your foreign parent, if your company is foreign owned.

Scenario 1: Your company is publicly traded. Report worldwide R&D expense as reported on SEC Form 10-K as defined in FASB ASC Topic 730, Research and Development (FASB Statement No. 2, “Accounting for Research and Development Costs.”)

Scenario 2: Your company is foreign-owned. Report the R&D expense figure of the U.S.-located company and domestic and foreign subsidiaries that are more than 50% owned by your U.S.-located company, if any. Do not include expenses by your foreign parent or by any foreign affiliate your U.S.-located company does not own. For reporting purposes, these entities should be treated the same as any unrelated third party such as a customer or supplier you do not own.

Scenario 3: Your company is privately owned. You should follow the same procedures as public companies when reporting R&D expense and follow the guidance in FASB ASC Topic 730, Research and Development (FASB Statement No. 2, “Accounting for Research and Development Costs.”). Privately held companies that cannot report on this basis should note reporting principles and difficulties in the space for "Remarks" at the end of the survey.

The following are examples of activities that typically would be excluded from research

and development in accordance with FASB Statement No. 2, “Activities Constituting Research and Development” (http://www.fasb.org/pdf/fas2.pdf) :

Engineering follow-through in an early phase of commercial production.
Quality control during commercial production including routine testing of products.
Trouble-shooting in connection with break-downs during commercial production.
Routine, on-going efforts to refine, enrich, or otherwise improve upon the qualities of an

existing product.

Adaptation of an existing capability to a particular requirement or customer's need as part of a continuing commercial activity.
Seasonal or other periodic design changes to existing products.
Routine design of tools, jigs, molds, and dies.
Activity, including design and construction engineering, related to the construction,

relocation, rearrangement, or start-up of facilities or equipment other than (1) pilot plants

(see paragraph 9(h)) and (2) facilities or equipment whose sole use is for a particular

research and development project (see paragraph 11(a)).

Legal work in connection with patent applications or litigation, and the sale or licensing of patents.

Exclude from worldwide R&D expense:

Costs for R&D that was paid for by a 3rd party such as R&D performed under contract.
For medical products companies, exclude costs for phase IV clinical trials since these trials take place after products have achieved technical and market feasibility.

Research and development activity in software:

Does R&D include development of software and Internet applications?

Yes, as long as the research and development activities include an element of uncertainty, are intended to close knowledge gaps, and meet scientific and technological needs.
Report in this survey all software R&D as defined here regardless of the eventual user (internal or external).

R&D activity in software includes:

Software development or improvement activities that expand scientific or technological knowledge
Construction of new theories and algorithms in the field of computer science

R&D activity in software EXCLUDES:

Software development that does not depend on a scientific or technological advance, such as:
- supporting or adapting existing systems
- adding functionality to existing application programs, and
- routine debugging of existing systems and software
Creation of new software based on known methods and applications
Conversion or translation of existing software and software languages
Adaptation of a product to a specific client, unless knowledge that significantly improved the base program was added in that process

For further guidance on accounting for software development costs see FASB Statement No. 86 (Accounting for the Costs of Computer Software to Be Sold, Leased); and FASB Interpretation No. 6 (Applicability of FASB Statement No. 2 to Computer Software).

2-2 Does the amount reported in Question 2-1 include any of the following costs?

Although most companies share a general framework for R&D, we request that certain items be excluded for the sake of consistency. Certain costs and expenses are to be reported in Section 3 reflecting your company’s R&D activities that was paid for by others.

Question 2-2 asks whether the company’s R&D expense figure reported in Question 2-1 included costs for five specific categories:

Collaborative R&D that was reimbursed by business partners, such as through cost-sharing agreements
- These agreements are very common in the biotechnology and pharmaceutical industries, but less so in other industries.
R&D paid for by government or private foundation grants
- Examples include Small Business Innovation and Research (SBIR) grants, Department of Energy demonstration grants, and Gates Foundation research grants.
Technical services not an integral part of an R&D project (such as product support provided by R&D employees)
- This category most often applies to software and service companies where R&D staff also provide technical support and/or services to customers
Bid and proposal costs
- This category represents the costs a company incurs applying to win a contract. Some government contractors group these costs with their R&D spending.
Expense your company claimed resulting from the acquisition of another company with unfinished R&D projects (In-process R&D).

Why is this important?

Not all companies treat the five cost categories listed in this question consistently with respect to their inclusion or exclusion from R&D expense figures. This question allows the survey to measure and correct for these inconsistencies

R&D paid for by your company

2-6 Of the amount reported in Question 2-4, what were the costs for each business code listed or amended on page 6 of this form?

If the company does not track its R&D costs by line of business or product line, it should make a reasonable estimate.

If the company has R&D that applies to more than one business code, such as basic or applied research conducted by a central R&D group, it should allocate this R&D to all applicable business codes on a reasonable basis. Examples of allocation methods include allocating in proportion to sales by business code and allocating in proportion to R&D employees working for each business code.

2-7 Of the amount reported in Question 2-4, what costs were incurred by your company in the following locations?

This question requires the company to report where R&D costs were incurred, even in the case of purchased R&D services where the R&D may be performed in a different location.

This survey defines the domestic United States as the 50 states and the District of Columbia only. Costs incurred in Puerto Rico, Guam, and other U.S. territories should be reported in the category for “All other countries”.

Report R&D performed by domestic operations that are paid for by foreign subsidiaries in line a (Domestic U.S.).

Report R&D performed by foreign subsidiaries that are paid for by domestic operations in line b (All other countries).

Report R&D total in line c. This should equal Question 2-4.

Scenario 1: Your company has R&D operations in Washington state and in your subsidiary in Canada. All of the R&D costs (such as salaries of R&D employees) from the Washington R&D operations should be reported in the line for “Domestic U.S.” even if a portion of this R&D is for the benefit of your Canadian subsidiary.

2-8 Copy the amount from Question 2-7, line a. This is the total domestic R&D paid for by your company in 2014.

Question 2-8 asks the company to copy the amount reported in Question 2-7 for R&D costs incurred in the domestic United States. This survey defines this amount as “total domestic R&D paid for by your company in 2014”.

2-9 Copy the amount from Question 2-7, line b. This is the total foreign R&D paid for by your company in 2014.

Question 2-9 asks the company to copy the amount reported in Question 2-7 for R&D costs incurred in countries outside the domestic United States. This survey defines this amount as “total foreign R&D paid for by your company in 2014”.

2-10 How much of the (1) domestic, (2) foreign, and (3) total worldwide R&D paid for by your company in 2014 was for each of the following types of costs?

Question 2-10 asks the company to report its domestic, foreign, and total worldwide R&D that it paid for in 2013 broken into 11 categories:

Salaries, wages, and fringe benefits
- Include costs for all compensation and benefits of R&D employees and officers that are included in the R&D paid for by the company.
- Stock-based compensation should be reported in line b
- Include payroll taxes such as Social Security and Medicare
Stock-based compensation
- Include the cost of both stock options and stock grants.
Temporary staffing including on-site consultants
- Include costs paid to Professional Employer Organizations (PEOs), staffing agencies, and on-site consultants for personnel contributing to R&D.
Expensed equipment
- Include all equipment purchases for R&D that are beneath the company’s capitalization threshold.
Materials and supplies
- Costs for materials and supplies consumed for R&D.
Leased facilities and equipment
- Costs for leased facilities and equipment used in the company’s R&D.
Depreciation and amortization on R&D property and equipment
- Includes depreciation on tangible R&D assets such as buildings or equipment as well as the amortization of intangible assets such as patents and capitalized in-process R&D used only for the company’s R&D activities.
Payments to business partners for collaborative R&D
- Include milestone payments and payments made under cost sharing agreements for joint R&D projects.
- Payments made to contract research organizations or other parties performing R&D under contract for the company should be reported in line i, “Purchased R&D services”.
Purchased R&D services
- Include payments made to contract research organizations or other parties performing R&D under contract for the company.
All other purchased services except R&D
- Include payments for purchased services that support the company’s R&D, but are not themselves R&D.
- Examples of costs to report in this category include hazardous waste disposal services at the company’s R&D lab and purchased computing time to run simulations for the company’s R&D.
All other costs
- Include all other costs supporting the R&D the company paid for.
- Examples of costs to report in this category include: travel and training, journal subscriptions, royalties or licenses paid for patents or software used in the company’s R&D
Total

The domestic total should equal Question 2-8, foreign total should equal Question 2-9, and total worldwide should equal Question 2-4.

2-11 Add 2-10, lines h and i for each column, and enter the result here. This is R&D performed by others.

Question 2-11 asks the company to add the amounts reported in Question 2-10, lines h and i for each column. This survey defines this amount as “R&D performed by others”.

Why is this important?

The costs reported in lines h and i of Question 2-10 represent payments to 3^rd parties (outsourcing) for R&D. Because the reporting company is not directly involved in the conduct of this R&D, it may not be able to provide the same amount of information on these costs as it could for the R&D it performs itself. This question allows the survey to address this limitation as well as address an interest in the nature of collaborative and contract R&D.

R&D transactions between legal entities under common ownership

Questions 2-22 and 2-23 are intended only for companies that own more than 50 percent of any operations or subsidiaries located outside the 50 United States and D.C. during 2013 (that is, your company provided a “Yes” response to Question 1-3).

2-22 How much of the amount reported in Question 2-15 (domestic R&D performance) was paid for by your company’s foreign subsidiaries through inter-company transactions?

Example: If an R&D activity were performed by employees in Texas U.S. [reported in 2-15], and charged both to operating units in the U.S. and to majority-owned subsidiaries in Belgium, then the costs charged to majority-owned subsidiaries in Belgium would be reported in 2-22.

Special Instruction for Foreign Owned Companies: Do not include payments from your company’s foreign parent. R&D costs associated with these payments should be reported in Section 3.

2-23 How much of the amount reported in 2-13 (foreign R&D performance) was paid for by your company’s domestic operations through inter-company transactions?

Example: Company Y owns a subsidiary in France. In order to complete the development of a product in 2014, the French subsidiary paid for R&D performed at Company Y’s U.S. R&D center. The cost of the U.S. R&D that was paid for by the French subsidiary would be included in this item.

R&D performed by others

2-24 Copy the amount from Question 2-11, column 1. This is the domestic R&D paid for by your company in 2014 that was performed by others.

This survey defines this amount as “total R&D performed by others in 2014”. This amount represents the R&D that your company outsourced or paid to third parties during 2013.

2-25 How much of the amount reported in Question 2-24 was performed by the following types of organizations?

Question 2-25 asks the company to report how much of the domestic R&D paid for by your company in 2014 that was performed by eight specific types of organizations:

Companies located inside the United States
- Include for-profit hospitals
Your company’s foreign parent (if you are owned by a foreign parent)
Other companies located outside the United States
U.S. federal government agencies or laboratories
U.S. state and local government agencies or laboratories
Foreign government agencies or laboratories
All other organizations inside the United States
All other organizations outside the United States
Total domestic R&D paid for by your company that was performed by others (equals Question 2-24)

Activities with academia

2-26 In addition to the amount reported in Question 2-24, did your company make monetary gifts to universities or colleges in 2014 that were restricted to support R&D?

If you answer “Yes”, skip to Question 2-27. If you answer “No”, skip to Question 2-28.

2-27 What was the amount of monetary gifts made by your company to universities or colleges in 2014 that were restricted to supporting R&D?

Indirect R&D charges

2-28 How much of the amount reported in Question 2-4 was for R&D costs your company plans to recoup through indirect charges on U.S. federal government contracts (IR&D or independent R&D)?

Question 2-28 asks how much of the amount reported in Question 2-4 was a special category of R&D costs tracked by government contractors. In order to encourage business R&D in certain areas of interest to the government, federal agencies such as the Department of Defense allow companies to recoup certain R&D costs through indirect charges on government contracts. These R&D costs, called IR&D or independent R&D should only apply to Federal government contractors.

Projected R&D for 2015

2-29 What are your company’s projected 2015 costs for (1) domestic, (2) foreign, and (3) total worldwide R&D paid for by your company?

Question 2-29 asks the company to project its domestic, foreign, and total worldwide R&D costs for 2015.

2-30 How much of the amount reported in Question 2-27, column 1, is for projected purchased R&D services and projected payments to business partners for collaborative R&D?

Question 2-30 asks the company to project how much of the domestic R&D paid for by the company in 2014 will be for purchased R&D services and payments to business partners for collaborative R&D.

Capital expenditures

2-31 What was the amount of your company’s capital expenditures in the domestic United States in 2014?

Exclude the cost of purchased land.

Assets acquired through merger and acquisition activities should not be included in your report.

2-32 How much of the amount reported in Question 2-29 was for R&D operations?

Companies should allocate capital expenditures that benefit both R&D operations and other company operations on a reasonable basis. Companies should note their allocation method in the space for "Remarks" at the end of the survey.

2-33 How much of the amount reported in Question 2-30 was for the following?

Question 2-33 asks the company to report how much of the domestic capital expenditures for R&D operations may be classified in four specific types or capital expenditures:

Structures
- Include the costs of purchased or improved buildings and other facilities such as signal towers or windmills that are fixed to the land.
Equipment
Capitalized software
All other capital expenditures for R&D operations
- Include the costs of purchased patents or other intangible assets.
Total domestic capital expenditures for R&D (equals Question 2-30)

Reporting Information

2-34 Is the information in this section reported for the 2014 calendar year?

If your company is reporting on a fiscal year that does not end Dec. 31, 2014, write what time period you are covering in the designated boxes.

Section 3: Financial Schedule B

3-1 What were your company’s total worldwide costs (both direct and indirect) in 2014 for the following that were funded, paid for, or reimbursed by others not owned by your company?

Costs should be considered “funded, paid for, or reimbursed by others” if the company has been or expects to be paid for the costs by a customer, business partner, or grant-making organization.

Note: Foreign-owned companies should report costs that are funded, paid for, or reimbursed by their foreign parent in this question.

Exclude: payments in excess of the actual cost of the work performed (such as profits or fees), and costs that were paid for by your company, such as those reported in Question 2-4 should not be double counted in this question.

If your company administers a federally-funded research and development center (FFRDC) for an agency of the federal government, all such R&D costs should be excluded for reporting to this survey. For a complete list of FFRDCs, see http://www.nsf.gov/statistics/ffrdclist/.

The categories in this question, listed below, define what the survey terms, “R&D paid for by others”:

R&D that was reimbursed by your company’s foreign parent (if you are owned by a foreign parent)
Collaborative R&D that was reimbursed by business partners, such as through cost-sharing agreements

These agreements are very common in the biotechnology and pharmaceutical industries, but less so in other industries.

R&D paid for by government or private foundation grants

Examples include Small Business Innovation and Research (SBIR) grants, Department of Energy demonstration grants, and Gates Foundation research grants.

Defense RDT&E goods or services (including DOD 6.1 through 6.7 funding), provided as a prime or as a sub, to the government and/or government contractors

This category most often applies to defense contractors and subcontractors performing tasks such as designing, building, and testing prototypes of new military weapon systems and developing custom software for defense applications.
Include all defense R&D funded by the Department of Defense (DOD), the Department of Energy’s weapons programs, the Department of Homeland Security, and other Federal agencies.
R&D funds from DOD include all funds for research, development, test, and evaluation (RDT&E) activities (6.1 through 6.7 budget appropriations).
Include defense R&D performed as a prime contractor and/or as a subcontractor.

Medical nonclinical R&D services provided to others not owned by your company

Nonclinical (also known as preclinical) research and development involves research on potential medical products that does not involve human subjects. This R&D consists of both in vitro studies as well as studies using animal subjects.

Medical clinical trial Phase I-III services provided to others not owned by your company (include pass-through costs)

This category involves the testing of potential medical products in human subjects. Phase I – III clinical trials must be successfully passed in order for a product to be approved for use in the general population.
Exclude costs for Phase IV clinical trials because these trials take place after a product has been approved for sale.

Nondefense custom software development and/or computer systems designed for others not owned by your company

See definitions in “Research and development activity in software” under guidance for Question 2-1.
This category includes the development of new or significantly improved software, both as an end product and for use embedded in other products.
Exclude: Software development that does not depend on a scientific or technological advance, such as adding functionality to existing application programs, debugging systems, and adapting existing software.
Software development for defense-related applications should be reported in line d.

Prototype development, production, and testing for customer’s products prior to their introduction to the market (excluding defense-related prototyping reported in line d)

Exclude quality control testing and other testing services for products already on the market.

All other R&D, not included above, provided to the Federal Government or to others not owned by your company
Total

3-2 Copy the amount from 3-1, line j. This is the total R&D paid for by others in 2014.

Question 3-2 asks the company to copy the amount reported in Question 3-1, line j. This survey defines this amount as “total R&D paid for by others” in 2014.

3-3 Is the amount entered in Question 3-2 greater than zero?

Question 3-3 instructs the company to skip to Section 4 on page 35 if its response to Question

3-2 is zero.

R&D paid for by others

3-4 Of the amount reported in Question 3-2, what costs were incurred by your company in the following locations?

This question requires the company to report where R&D costs were incurred, even in the case of purchased R&D services where the R&D may be performed in a different location.

3-5 Copy the amount from Question 3-4, line a. This is the total domestic R&D paid for by others in 2014.

Question 3-5 asks the company to copy the amount reported in Question 3-4, line a, for R&D costs in the domestic United States. This survey defines this amount as “total domestic R&D paid for by others” in 2014.

3-6 Copy the amount from Question 3-4, line b. This is the total foreign R&D paid for by others in 2014.

Question 3-6 asks the company to copy the amount reported in Question 3-4, line b, for R&D costs in countries outside the domestic United States. This survey defines this amount as “total foreign R&D paid for by others” in 2013.

3-7 How much of the (1) domestic, (2) foreign, and (3) total worldwide R&D paid for by others in 2014 was for each of the following types of costs?

Question 3-7 asks the company to report its domestic, foreign, and total worldwide R&D paid for by others in 2014 broken into 11 categories:

Salaries, wages, and fringe benefits

Include costs for all compensation and benefits of R&D employees and officers that are included in the R&D paid for by others.
Stock-based compensation should be reported in line b.
Include payroll taxes such as Social Security and Medicare

Stock-based compensation

Includes the cost of both stock options and stock grants.

Temporary staffing, including on-site consultants

Include costs paid to Professional Employer Organizations (PEOs), staffing agencies, and on-site consultants for personnel contributing to R&D

Expensed equipment

Include all equipment purchases for R&D that are beneath the company’s capitalization threshold.

Materials and supplies

Costs for materials and supplies consumed for R&D.

Leased facilities and equipment

Costs for leased facilities and equipment used in the R&D.

Depreciation and amortization on R&D property and equipment

Include depreciation on tangible R&D assets such as buildings or equipment as well as the amortization of intangible assets such as patents and capitalized in-process R&D used only for the company’s R&D activities.

Payments to business partners for collaborative R&D

Include payments made to business partners for collaborative R&D, including milestone payments and payments made under cost sharing agreements for joint R&D projects.
Payments made to contract research organizations or other parties performing R&D under contract for the company should be reported in line i, “Purchased R&D services”.

Purchased R&D services (if your company is foreign-owned, include payments to your foreign owner for R&D)

Include payments made to contract research organizations or other parties performing R&D under contract for the company.
Include defense R&D funding that your company received as a prime that is subcontracted to others not owned by your company

All other purchased services except R&D

Include payments for purchased services that support the company’s R&D, but are not themselves R&D.
Examples of costs to report in this category include hazardous waste disposal services at the company’s R&D lab and purchased computing time to run simulations for the company’s R&D.

All other costs

Include all other costs supporting the R&D the company paid for.

Examples of costs to report in this category include: travel and training, journal subscriptions, royalties or licenses paid for patents or software used in the company’s R&D.Total (domestic total equals Question 3-5, foreign total equals Question 3-6, and total worldwide equals Question 3-2)

3-8 Add 3-7, lines h and i for each column, and enter the result here. This is R&D performed by others (e.g. subcontracted/passed-through R&D costs).

Question 3-8 asks the company to add the amounts reported in Question 3-7, lines h and i for each column. This survey defines this amount as “R&D performed by others”.

Why is this important?

The costs reported in lines h and i of Question 3-7 represent payments to 3^rd parties for R&D. Because the reporting company is not directly involved in the conduct of this R&D, it may not be able to provide the same amount of information on these costs as it could for the R&D it performs itself. This question allows the survey to address this limitation as well as address an interest in the nature of collaborative and contract R&D.

3-12 Copy the amount from Question 3-9, column 1. This is the domestic R&D performed by your company that was paid for by others.

Question 3-12 asks the company to copy the amount reported in Question 3-9 for domestic R&D costs performed by the company that was paid for by others. This survey defines this amount as “domestic R&D performed by your company that was paid for by others”.

3-13 How much of the domestic R&D performed by your company that was paid for by others reported in Question 3-12 was for each business code listed or amended on page 6 of this form?

If the company does not track its R&D costs by line of business or product line, it should make a reasonable estimate.

3-14 How much of the amount reported in Question 3-12, was paid for by each of the following?

Question 3-14 asks the company to report how much of the domestic R&D paid for by your company in 2014? that was performed by nine specific types of organizations:

Example: Company Sub Inc. performs custom software development for a large defense company as a subcontractor with the U.S. Dept. of Defense. Even though Sub Inc. is working directly for the defense company, it reports the cost of this development in line d because the Dept. of Defense was the original source of funds.

Other companies located inside the United States
- Include for-profit hospitals
Your company’s foreign parent (if you are owned by a foreign parent)
Other companies located outside the United States
U.S. federal government agencies or laboratories
U.S. state government agencies or laboratories
Foreign government agencies or laboratories
All other organizations inside the United States
All other organizations located outside the United States
Total (equals Question 3-12)

3-15 Add Question 3-14, lines a, b, and c, and enter the result here. This is the R&D that was paid for by other companies.

Question 3-15 asks the company to enter the sum of Question 3-14, lines a, b, and c. This survey defines this amount as “R&D that was paid for by other companies”.

3-16 Using the list of business codes printed below, allocate the amount reported in Question 3-15 based on the industries of the companies that paid for the R&D. As needed, enter additional codes from pages 46-47 in the spaces provided.

These business codes should represent the industry of the company that is funding the R&D.

For example, if Company A specializes in R&D services in biotechnology (business code 54173) and is performing research and development for Company B, a pharmaceutical company (business code 32541), Company B’s business code (32541) should be listed here.

Enter the total, which should be equal to Question 3-15.

3-17 Copy the amount from Question 3-14, line d. This is domestic R&D performed by your company that was paid for by the U.S. federal government.

Question 3-17 asks the company to copy the amount reported in Question 3-14, line d. This survey defines this amount as “domestic R&D performed by your company that was paid for by the U.S. federal government”.

3-18 How much of the amount reported in Question 3-17 was paid for by the following agencies?

Question 3-18 asks the company to report the amount of R&D it performed in the domestic U.S. that was paid for by the U.S. Federal Government specific funding agencies.

3-19 How much of the amount reported in Question 3-17 was performed under the following types of agreements?

Contracts (include direct or prime contracts and subcontracts)
Grants, reimbursements, and all other agreements
Total (equals Question 3-17)

Question 3-19 asks the company to identify the amounts by type of agreements used for the company’s domestic R&D paid for by the U.S. federal government.

3-20 Subtract Question 3-17 from Question 3-12 and enter the result here. This is the domestic R&D performed by your company that was paid for by nonfederal sources.

Question 3-20 asks the company to subtract the amount reported in Question 3-17 from that reported in Question 3-12. This survey defines this amount as “domestic R&D performed by your company that was paid for by nonfederal sources”.

3-21 How much of the following three amounts was performed in each state (including D.C.): (1) Domestic R&D paid for by the U.S. federal government reported in Question 3-17, (2) Domestic R&D paid for by nonfederal sources reported in Question 3-20, (3) Total domestic R&D performed by your company that was paid for by others reported in Question 3-12.

Question 3-21 asks the company to report how much of the domestic R&D it performed that was paid for by others was performed in each state (including D.C.) in 2013. The question asks the company to report how much of the R&D in each state was paid for by the U.S. federal government as opposed to all other sources. If the company is unable to assign all its R&D costs to specific states, it should use a reasonable allocation method to report R&D by state. Companies should note their allocation method in the space for "Remarks" at the end of the survey.

Why is this important?

This information is very important to policy makers who are interested in the geographic distribution of R&D activity and its role in regional economic development.

3-22 At what domestic location did your company perform the largest dollar amount of R&D that was paid for by others in 2014?

Question 3-22 asks the company to identify the location where the largest dollar value of the domestic R&D it performed that was paid for by others in 2014 took place.

3-23 How much of the amount reported in Question 3-12 was from the location identified in Question 3-22?

3-24 At what domestic location did your company perform the second largest dollar amount of R&D that was paid for by others in 2014?

Question 3-24 asks the company to identify the location where the second largest dollar value of the domestic R&D it performed that was paid for by others in 2014 took place.

3-25 How much of the amount reported in Question 3-12 was from the location identified in Question 3-24?

Projected R&D paid for by others in 2015

3-26 What are your company’s projected 2015 costs for R&D that will be paid for by others?

Question 3-26 asks the company to project its 2015 costs for R&D that will be paid for by others.

This amount is the 2015 projection for what is reported in Question 3-2.

3-27 How much of the projected costs in 2015? for R&D that will be paid for by others reported in Question 3-26 will be performed by your company in the United States?

Question 3-27 asks the company to project its 2015? costs for R&D it will perform in the domestic U.S. that will be paid for by others. This amount is the 2015? projection for what is reported in Question 3-12.

3-28 How much of the projected costs in 2015? for domestic R&D performed by your company that will be paid for by others reported in Question 3-27 will be paid for by the U.S. federal government?

Question 3-28 asks the company to project its 2015? costs for R&D it will perform in the domestic U.S. that will be paid for by the U.S. federal government. This amount is the 2015?projection for what is reported in Question 3-17.

Section 4: Management and Strategy of R&D

4-1 Copy the amount from Question 2-4. This is the total R&D paid for by your company in 2014.

This number can be found on page 10 of Form BRDI-1.

4-2 Is the amount entered in Question 4-1 greater than zero?

If no, questions 4-3 through 4-11 do not apply to your company. Please do not complete these questions. Skip to question 4-17 on page 37.

4-3 What percentage of the amount reported in Question 4-1 was directed toward business areas or product lines that are new to your company?

Question 4-3 asks what percent of the R&D the company paid for in 2013 was aimed at expanding the company’s areas of business or product lines outside of its existing areas of expertise. The characteristics that define a business area or product line as “new” may differ from company to company and industry to industry, but they generally involve technologies and customers that are new to the company.

Example: Company A manufactures laptop computers. In 2014, Company A’s management decided to attempt to enter the cellular phone market and used a portion of the company’s R&D budget to develop cellular phones. Because this was a ndw line of business in 2014, Company A reports this R&D in this question.

The following are examples of R&D projects that would be reported in this question:

A pharmaceutical company that specializes in anti-viral medications invests in a research project to develop a cancer treatment.
A computer manufacturer invests in a project to develop a smart phone.
A software company that specializes in anti-virus software invests in an R&D project to develop office productivity software.
A semiconductor company that specializes in central processing units for computers invests in an R&D project to develop graphics processors.
A manufacturer and distributor of beer invests in an R&D project to develop an energy drink.

Characteristics of domestic R&D paid for and performed by your company

4-4 Copy the amount from Question 2-15. This is the domestic R&D paid for and performed by your company.

This number can be found on page 14 of Form BRDI-1.

4-5 How much of the amount reported in Question 4-4 was for the following categories?

Research is defined as experimental or theoretical work undertaken primarily to acquire new knowledge or understanding of phenomena and observable facts. Research may be either “basic”, where the goal is primarily to increase understanding of a given topic without a specific commercial application in mind, or “applied”, there the goal is to solve a specific problem or achieve a specific commercial objective.

Development is defined as the systematic use of research and practical experience to produce new or significantly improved goods, services, or processes. In simple terms, the intended output of research is ideas and the intended output of development is products.

4-6 If you reported any research in Question 4-5, line a, how much of that research was for the following categories?

Research is defined as experimental or theoretical work undertaken primarily to acquire new knowledge or understanding of phenomena and observable facts. Applied research has the goal of solving a specific problem or achieving a specific commercial objective. Basic research has the goal of increasing understanding of a given topic without a specific commercial application in mind.

For example, a project that aims to investigate the influence of different materials on fuel cell efficiency would be classified as basic research. A project that aims to improve fuel cell efficiency using new materials would be classified as applied research.

Areas of application for domestic R&D paid for and performed by your company

NOTE: You may report the same R&D in multiple areas for Questions 4-7 to 4-11.

4-7 What percentage of the amount reported in Question 4-4 had energy applications, including energy production, distribution, storage, and efficiency (excluding exploration and prospecting)?

The intent of this question is to measure the amount of R&D companies are investing in energy-related applications.

Only include costs for R&D projects where energy was an intended area of application from its inception. Do not include costs for R&D projects where energy was not an intended area of application until after the project was completed.

Include the total cost of an R&D project with energy applications in the calculation for this question even if the project has other applications. This means that the percentages reported in Questions 4-7 through 4-11 could add to more than 100%.

Example: Company B is a semiconductor manufacturer. Its products are not designed specifically for energy applications. In 2014, 10% of the domestic R&D performed by the company was focused on improving the energy efficiency of its products. Based on this, Company B reports “10%” for this question.

4-8 What percentage of the amount reported in Question 4-4 had environmental protection applications, including pollution abatement?

The intent of this question is to measure the amounts of R&D companies are investing in environmental protection applications.

Only include costs for R&D projects where environmental protection was an intended area of application from its inception. Do not include costs for R&D projects where environmental protection was not an intended area of application until after the project was completed.

Include the total cost of an R&D project with environmental protection applications in the calculation for this question even if the project has other applications. This means that the percentages reported in Questions 4-7 through 4-11 could add to more than 100%.

4-9 What percentage of the amount reported in Question 4-4 had defense applications, including military applications and general security-related R&D?

The intent of this question is to measure the amount of R&D companies are investing in defense applications. Defense applications include military applications and other national security applications. Exclude R&D for computer security applications such as anti-virus software unless it is intended for military/national security use.

Only include costs for R&D projects where defense was an intended area of application from its inception. Do not include costs for R&D projects where defense was not an intended area of application until after the project was completed.

Include the total cost of an R&D project with defense applications in the calculation for this question even if the project has other applications. This means that the percentages reported in Questions 4-7 through 4-11 could add to more than 100%.

4-10 What percentage of the amount reported in Question 4-4 had health or medical applications?

Question 4-10 asks the company to report what percent of the domestic R&D it performed in 2013 had health or medical applications. The intent of this question is to measure the amount of R&D companies are investing in health-related applications.

Only include costs for R&D projects where health was an intended area of application from its inception. Do not include costs for R&D projects where health was not an intended area of application until after the project was completed.

Include the total cost of an R&D project with health/medical applications in the calculation for this question even if the project has other applications. This means that the percentages reported in Questions 4-7 through 4-11 could add to more than 100%.

Note: Include clinical trials.

4-11 What percentage of the amount reported in Question 4-4 had agricultural applications?

This includes R&D into new and significantly improved fertilizers, pesticides, farm equipment, and crop management techniques. The intent of this question is to measure the amount of R&D companies are investing in agricultural-related applications.

Only include costs for R&D projects where agriculture was an intended area of application from its inception. Do not include costs for R&D projects where agriculture was not an intended area of application until after the project was completed.

Include the total cost of an R&D project with agricultural applications in the calculation for this question even if the project has other applications. This means that the percentages reported in Questions 4-7 through 4-11 could add to more than 100%.

Technology focus of domestic R&D paid for and performed by your company

NOTE: You may report the same R&D in multiple areas for Questions 4-12 to 4-16.

4-12 What percentage of the amount reported in Question 4-4 was for software products or software embedded in other projects or products?

See definitions in “Research and development activity in software” under guidance for Question 2-1. Include R&D in software for both packaged software that is sold/licensed to consumers as well as R&D in software for internet applications that generate revenue. This includes R&D in software developed specifically for an R&D project that has no alternative future use as well as R&D in software that is developed to be installed or run in other products sold by the company.

Include the total cost of an R&D project with software applications in the calculation for this question, even if the project has other applications. This means that the percentages reported in Questions 4-12 through 4-16 could add to more than 100%.

4-13 What percentage of the amount reported in Question 4-4 was for optics and photonics- science and technology involving the emission, processing, and detection of light, or the information carried by light?

Optics and photonics can encompass any R&D project involved in the study of the emission, processing, and detection of light, or of the information carried by light. This includes the spectrum ranging from the far infrared to x-rays. The R&D may be directed at the manufacturing of the optics and photonics product itself, or to any level of the application supply chain in which they are used (from materials studies to systems development or even the end-use application).

The following list provides examples of optics and photonics technologies. The list is not intended to be exhaustive, but it is indicative of the types of activities included in the definition of optics and photonics.

Optical semiconductor components, such as LEDs, laser diodes, image sensors, focal plane arrays, point detectors, and integrated photonics
Solar (photovoltaic) cells and panels
Displays, display components and subassemblies
Lasers and laser systems
LEDs, LED backlights, LED lamps, and LED lighting
Optical fiber, cabled fiber, and optical fiber devices, such as fiber sensors
Passive optics, such as lenses, mirrors, prisms, and crystals
Coatings and coating services for optics and optical devices
Optical assemblies, such as lens systems, sensor subsystems, and camera modules
Hardware and software design of the above products

Include the total cost of an R&D project with optics and photonics applications in the calculation for this question, even if the project has other applications. This means that the percentages reported in Questions 4-12 through 4-16 could add to more than 100%.

Patents

6-1 How many patents did your company apply for in 2014 from the U.S. Patent and Trademark Office (USPTO)?

The intent of this question is to gather information about the output of companies’ patenting activities. It is recognized that companies do not attempt to patent every invention, and that not every patent application results from an organized R&D activity.

Exclude the following types of continuing patent applications that do not add subject matter claimed in the parent patent application: continuation applications, requests for continued examination, divisional patent applications, and reissue applications. These types of patent applications are excluded to avoid double counting applications for the same subject matter. Continuation-in-part applications should be included because they add subject matter not claimed in the parent patent application.

Exclude provisional patent applications.

Foreign-owned companies that apply for U.S. patents on behalf of their foreign parents should only report the patent applications originating from its own operations. Patents filed on behalf of others not owned by the company (such as a foreign parent) should be excluded.

6-2 What percentage of the patent applications reported in Question 61 has your company applied for or plans to apply for in foreign jurisdictions?

This information is useful as a measure of innovation both because it is an indicator of the potential global import of an invention and because it may indicate that the subject matter of the patent application is of high value.

6-3 What percentage of the patent applications reported in Question 61 was for inventions that originated within your company's organized R&D activities?

Exclude patent applications where none of the named inventors are R&D employees.

6-4 How many patents were issued to your company in 2014 by the USPTO?

Foreign-owned companies that apply for U.S. patents on behalf of their foreign parents should only report the patent grants that originated from its own operations. Patents filed on behalf of others not owned by the company (such as a foreign parent) should be excluded. In general, the company should only report patents for which it (the reporting company including its subsidiaries) is an assignee.

6-5 What percentage of your company's inventions considered for patenting in 2014 resulted in patent applications?

Many companies track this information through formal invention disclosure reports. This information is important because it provides a means to evaluate how useful patent applications are as a measure of innovation when comparing industries.

Exclude provisional patent applications.

Patent sales and licensing to others

6-6 How much revenue did your company receive in 2014 from the sale of patents?

Question 6-6 asks the company to report the revenue it earned in 2014 from the sale of its patents. Companies should only report revenue from the licensing of patents it (the reporting company) owns. Exclude revenue from sub-licensing.

Companies should only report revenue from licensing of patents to companies/organizations not owned by the reporting company. If a reporting company is foreign-owned, it should report revenue generated from licensing patents to its foreign owner and to other affiliated companies it does not own.

6-7 How much revenue did your company receive in 2014 from patent licensing?

Question 6-7 asks the company to report how much revenue it received in 2014 to license its patents to other parties.

Patent purchases and licensing from others

6-8 How much did your company pay others in 2014 to purchase patents?

Question 6-8 asks the company to report how much it paid to others to purchase patents in 2014.

6-9 How much did your company pay others in 2014 to license patents?

Question 6-9 asks the company to report how much it paid to others to license patents in 2014.

6-10 How many new agreements did your company enter into during 2014 to license patents to others not owned by your company?

Question 6-10 asks the company to report how many new agreements were entered in 2014 ot license patents to others not owned by the company.

Intellectual property transfer activities

6-11 Did your company perform the following activities in 2014?

Question 6-11 asks the company to indicate whether or not it performed any of a specific list of technology transfer activities in 2014.

Intellectual property protection

6-12 During 2014, how important to your company were the following types of intellectual property protection?

Question 6-12 asks the company to indicate the importance of different methods of intellectual property protection to its business.

File Type	application/vnd.openxmlformats-officedocument.wordprocessingml.document
Author	Samuel W. Fincher
File Modified	0000-00-00
File Created	2021-01-25